20/20 Biolabs, Inc.
AIDX
$1.46
$0.096.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.74M | -3.68M | -4.73M | -5.14M | -5.55M |
| Total Depreciation and Amortization | 85.80K | 98.30K | 112.10K | 125.30K | 138.50K |
| Total Amortization of Deferred Charges | 115.10K | 17.20K | 0.00 | 2.50K | 5.00K |
| Total Other Non-Cash Items | 781.40K | 1.05M | 1.82M | 2.00M | 2.19M |
| Change in Net Operating Assets | 836.80K | 568.50K | 656.40K | 638.00K | 619.60K |
| Cash from Operations | -1.92M | -1.94M | -2.14M | -2.37M | -2.60M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 988.50K | 576.60K | 70.00K | 35.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.80K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 192.40K | 302.40K | 382.10K | 337.70K | 293.30K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.90K | -- | -- | -- | -- |
| Cash from Financing | 1.16M | 879.00K | 452.10K | 372.70K | 293.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -758.00K | -1.07M | -1.69M | -2.00M | -2.31M |